Hs-CRP as a biomarker for atherosclerosis progression and cardiovascular risk: a systematic review
Systematic review supporting hs-CRP as a prognostic marker of atherosclerosis progression and cardiovascular risk.
Evidence
—
Not Rated
Sample
—
subjects
Duration
—
study period
Journal
—
Jan 2025
Structured Methods
- Study Design
- Systematic Review
- Sample Size
- Not reported
- Study Duration
- Not reported
- Methodology
- Not reported
- Limitations
- Not reported
Citations & References
Unknown authors (2025). Hs-CRP as a biomarker for atherosclerosis progression and cardiovascular risk: a systematic review.
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation
